Investing Profile

Marianne Uteng

VC
Managing Director at Novartis Venture Fund at Novartis Venture Fund
Photo of Marianne Uteng, Managing Director at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Novartis Network
54 CONNECTIONS
cb
Novartis Venture Fund Managing Director
$5.0M - $10.0M
$7.5M
5
$750M
CompanyStageDateRound SizeTotal Raised
Epsilogen
Series BSep 2024$16M
Series BMar 2022$41M
$63M
Co-investors: Marianne Bjørdal (3B Future Health Ventures (Helsinn Investment Fund)), Christoph Ruedig (AlbionVC)
AstronauTx
Series AOct 2023$59M
$60M
Co-investors: Simon Goldman (AlbionVC), Jonathan Tobin (Brandon Capital Partners), Laurence Barker (SV Health Investors' Dementia Discovery Fund (DDF))
Tagworks Pharmaceuticals
Series AJun 2023$65M
$65M
Co-investors: Christina Isacson (Lightstone Ventures), Michele Park (Clarus Ventures)
CatalYm
Series CNov 2022$52M
$200M
Co-investors: Colleen Cuffaro (Canaan Partners), Jon Edwards (Red Tree Venture Capital), Jonathan Tobin (Brandon Capital Partners), Oscar Slotboom (BGV (BioGeneration Ventures)), Nathalie Weitemeyer (Bayern Kapital), Rogier Rooswinkel (Hotmail)
Board Observer Rappta TherapeuticsPresent
Board Observer Amphista Therapeutics LimitedPresent
Board Director CatalYm GmbHPresent
Board Director Epsilogen LtdPresent
Board Observer CatalYm GmbHPresent
Member Board of Directors Tagworks PharmaceuticalsPresent
Managing Director at Novartis Venture Fund NovartisPresent
Member Board of Directors AstronauTxPresent
University of Oslo (UiO) Master's degree Biochemistry
University of Oslo Master's degree Biochemistry
European Molecular Biology Laboratory (EMBL) PhD Cell Biology & Biophysics